Product Information
URSODIOL 500 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.6818 per EA under NDC 00591300501. Its NADAC has been published 590 times since Feb 11, 2015.
FDA first approved this application on Dec 10, 1997.
Strength
500 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591300501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
URSODIOLApproval Type
Authorized Generic (NDA)
FDA Application
NDA020675FDA Approved
12/10/1997
On Market Since
12/10/1997
Pharmacological Classes
Price Statistics
The NADAC for URSODIOL 500 MG TABLET has been published 590 times since Feb 11, 2015, and over the history we have for it it has declined 74.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6818 per EA |
|---|---|
| All-time high | $3.3502 (Apr 13, 2016) |
| All-time low | $0.5191 (Jul 17, 2024) |
| 52-week high | $0.7692 |
| 52-week low | $0.6355 |
| Median price | $1.2217 |
| Average price | $1.4069 |
| Largest weekly change | -33.1% (Jul 17, 2024) |
| Weeks tracked | 590 |
| Tracking since | Feb 11, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
+2.2%
1Y
-11.4%
3Y
-8.1%
5Y
-38.8%
All
-74.0%
Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ursodiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bile Acid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of URSODIOL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for URSODIOL 500 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.6818 per EA (NDC 00591300501), effective May 27, 2026.
How has the price of URSODIOL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for URSODIOL 500 MG TABLET has declined 74.0%. It has been tracked across 590 weekly CMS publications since Feb 11, 2015.
What are the highest and lowest recorded NADAC prices for URSODIOL 500 MG TABLET?
Since Feb 11, 2015, the NADAC for URSODIOL 500 MG TABLET has ranged from a low of $0.5191 (Jul 17, 2024) to a high of $3.3502 (Apr 13, 2016), with a median of $1.2217 per EA.
Are there cheaper alternatives to URSODIOL 500 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, URSODIOL 500 MG TABLET, is $0.6471 per EA — about 5% below URSODIOL 500 MG TABLET.
Who manufactures URSODIOL 500 MG TABLET?
URSODIOL 500 MG TABLET (NDC 00591300501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.